This information was published on 2022-07-12T00:41:42 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2248801 |
| (220) |
11 Feb 2022
|
| (511) (510) |
Class 5
Antiviral pharmaceuticals for human use |
| (540) | DAL |
| (550) | Word |
| (730) |
Novartis AG
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.